A detailed history of Brandywine Global Investment Management, LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Brandywine Global Investment Management, LLC holds 29,083 shares of UTHR stock, worth $10.5 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
29,083
Previous 25,972 11.98%
Holding current value
$10.5 Million
Previous $8.27 Million 25.96%
% of portfolio
0.07%
Previous 0.06%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$311.04 - $363.55 $967,645 - $1.13 Million
3,111 Added 11.98%
29,083 $10.4 Million
Q2 2024

Aug 14, 2024

BUY
$228.26 - $319.04 $5.93 Million - $8.29 Million
25,972 New
25,972 $8.27 Million
Q4 2020

Feb 10, 2021

SELL
$101.87 - $151.79 $13.4 Million - $19.9 Million
-131,194 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$99.9 - $121.13 $617,481 - $748,704
-6,181 Reduced 4.5%
131,194 $13.3 Million
Q2 2020

Aug 14, 2020

SELL
$92.74 - $125.82 $516,098 - $700,188
-5,565 Reduced 3.89%
137,375 $16.6 Million
Q1 2020

May 15, 2020

BUY
$79.39 - $115.35 $11.3 Million - $16.5 Million
142,940 New
142,940 $13.6 Million
Q4 2019

Feb 14, 2020

SELL
$78.31 - $95.34 $8,222 - $10,010
-105 Closed
0 $0
Q3 2019

Nov 14, 2019

SELL
$74.85 - $85.99 $9.51 Million - $10.9 Million
-127,062 Reduced 99.92%
105 $9,000
Q2 2019

Aug 14, 2019

SELL
$76.06 - $120.81 $875,146 - $1.39 Million
-11,506 Reduced 8.3%
127,167 $9.93 Million
Q1 2019

May 15, 2019

BUY
$107.15 - $126.84 $30,216 - $35,768
282 Added 0.2%
138,673 $16.3 Million
Q4 2018

Feb 14, 2019

BUY
$101.4 - $128.73 $2.64 Million - $3.35 Million
26,035 Added 23.17%
138,391 $15.1 Million
Q3 2018

Nov 14, 2018

BUY
$113.81 - $129.46 $12.7 Million - $14.5 Million
112,021 Added 33439.1%
112,356 $14.4 Million
Q2 2018

Aug 14, 2018

BUY
$101.14 - $118.31 $21,846 - $25,554
216 Added 181.51%
335 $38,000
Q1 2018

May 15, 2018

BUY
$107.21 - $151.94 $1,500 - $2,127
14 Added 13.33%
119 $14,000
Q4 2017

Feb 14, 2018

SELL
$118.58 - $151.28 $9.07 Million - $11.6 Million
-76,461 Reduced 99.86%
105 $16,000
Q3 2017

Nov 14, 2017

SELL
$114.6 - $136.81 $5.52 Million - $6.59 Million
-48,144 Reduced 38.6%
76,566 $8.97 Million
Q2 2017

Aug 14, 2017

BUY
N/A
124,710
124,710 $16.2 Million

Others Institutions Holding UTHR

About UNITED THERAPEUTICS Corp


  • Ticker UTHR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,516,300
  • Market Cap $16.4B
  • Description
  • United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...
More about UTHR
Track This Portfolio

Track Brandywine Global Investment Management, LLC Portfolio

Follow Brandywine Global Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brandywine Global Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Brandywine Global Investment Management, LLC with notifications on news.